Search by Drug Name or NDC

NDC 53097-0571-60 MARINOL 2.5 mg/1 Details

MARINOL 2.5 mg/1

MARINOL is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ThePharmaNetwork, LLC. The primary component is DRONABINOL.

MedlinePlus Drug Summary

Dronabinol is used to treat nausea and vomiting caused by chemotherapy in people who have already taken other medications to treat this type of nausea and vomiting without good results. Dronabinol is also used to treat loss of appetite and weight loss in people who have acquired immunodeficiency syndrome (AIDS). Dronabinol is in a class of medications called cannabinoids. It works by affecting the area of the brain that controls nausea, vomiting, and appetite.

Related Packages: 53097-0571-60
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dronabinol

Product Information

NDC	53097-0571
Product ID	53097-571_5ce802d5-e8ab-4cd1-9ba0-1f39f22ddd48
Associated GPIs	50300030000110
GCN Sequence Number	004694
GCN Sequence Number Description	dronabinol CAPSULE 2.5 MG ORAL
HIC3	H6O
HIC3 Description	ANTIEMETIC, CANNABINOID-TYPE
GCN	27990
HICL Sequence Number	001955
HICL Sequence Number Description	DRONABINOL
Brand/Generic	Brand
Proprietary Name	MARINOL
Proprietary Name Suffix	n/a
Non-Proprietary Name	Dronabinol
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	2.5
Active Ingredient Units	mg/1
Substance Name	DRONABINOL
Labeler Name	ThePharmaNetwork, LLC
Pharmaceutical Class	Cannabinoid [EPC], Cannabinoids [CS]
DEA Schedule	CIII
Marketing Category	NDA
Application Number	NDA018651
Listing Certified Through	2024-12-31

Package

NDC 53097-0571-60 (53097057160)

Pricing Information	N/A
NDC Package Code	53097-571-60
Billing NDC	53097057160
Package	60 CAPSULE in 1 BOTTLE (53097-571-60)
Marketing Start Date	2021-03-03
NDC Exclude Flag	N